53 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis and structure activity relationships of glycine amide derivatives as novel Vascular Adhesion Protein-1 inhibitors.

Astellas Pharma
Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing pyridazinone moiety as potential antitumor agents.

Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University)
Novel 1H-imidazol-2-amine derivatives as potent and orally active vascular adhesion protein-1 (VAP-1) inhibitors for diabetic macular edema treatment.

Astellas Pharma
Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema: part 2.

Astellas Pharma
Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema.

Astellas Pharma
Synthesis, in vitro activity, and three-dimensional quantitative structure-activity relationship of novel hydrazine inhibitors of human vascular adhesion protein-1.

Fi-40014 University of Jyvaskyla
The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1).

Pharmaxis
Design, synthesis, and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity.

La Jolla Pharmaceutical
Alkylamino derivatives of 4-aminomethylpyridine as inhibitors of copper-containing amine oxidases.

University of Genoa
Novel hydrazine molecules as tools to understand the flexibility of vascular adhesion protein-1 ligand-binding site: toward more selective inhibitors.

University of Jyva£Skyla£
Silicon-mediated inactivation of semicarbazide-sensitive amine oxidase

TBA
Fluorinated phenylcyclopropylamines. Part 5: Effects of electron-withdrawing or -donating aryl substituents on the inhibition of monoamine oxidases A and B by 2-aryl-2-fluoro-cyclopropylamines.

UniversitäT MüNster
ω-(5-Phenyl-2H-tetrazol-2-yl)alkyl-substituted glycine amides and related compounds as inhibitors of the amine oxidase vascular adhesion protein-1 (VAP-1).

Monsters University
Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease.

Pharmaxis
Combinatorial synthesis of SSAO inhibitors using sonogashira coupling: SAR of aryl propargylic amines.

University of Technology
2-Aminomethylene-5-sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth.

University of Manchester
Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3.

Pharmaxis
Novel pyridazinone inhibitors for vascular adhesion protein-1 (VAP-1): old target-new inhibition mode.

Abo Akademi University
Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure-Activity Relationships.

The Institute of Cancer Research
Synthesis and pharmacological evaluation of glycine amide derivatives as novel vascular adhesion protein-1 inhibitors without CYP3A4 and CYP2C19 inhibition.

Astellas Pharma
Synthesis and structure activity relationships of carbamimidoylcarbamate derivatives as novel vascular adhesion protein-1 inhibitors.

Astellas Pharma
PYRAZOLE-SUBSTITUTED CYCLOPENTANOL ESTER DERIVATIVE AND USE THEREOF

Chia Tai Tianqing Pharmaceutical Group
Weed control methods and related compositions and plants

Syngenta Crop Protection
FUSED TRICYCLIC DERIVATIVE AND PHARMACEUTICAL APPLICATION THEREOF

Chia Tai Tianqing Pharmaceutical Group
IL-17A MODULATORS

Sanofi
Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors

Luoxin Pharmaceutical (Shanghai)
Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases

Janssen Sciences Ireland
CD73 inhibitors

Oric Pharmaceuticals
Difluoroketamide derivatives as HtrA1 inhibitors

Hoffmann-La Roche
EGFR proteolysis targeting chimeric molecules and associated methods of use

Arvinas Operations
Pyrazolopyrimidine derivatives as kinase inhibitor

Daewoong Pharmaceutical
Cannabinoid receptor mediating iminopyrazole compounds

The United States of America, As Represented By The Secretary, Department of Health and Human Services
Substituted piperazines as selective HDAC1,2 inhibitors

Regenacy Pharmaceuticals
Tricyclic sulfones as RORγ modulators

Bristol-Myers Squibb
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

Prelude Therapeutics
STK4 inhibitors for treatment of hematologic malignancies

Dana-Farber Cancer Institute
Substituted tetrahydrocarbazole and carbazole carboxamide compounds

Bristol-Myers Squibb
Heteroaryldiazepine derivatives as RSV inhibitors

Enanta Pharmaceuticals
Substituted pyridazines for the treatment of pain

Inhibitaxin
Materials and method for inhibiting replication protein A and uses thereof

Indiana University Research and Technology
Synthesis, biological evaluation and docking studies of new pyrrolo[2,3-d] pyrimidine derivatives as Src family-selective tyrosine kinase inhibitors.

Ankara University
Triazole carboxamides and uses thereof

Hoffmann-La Roche
Therapeutic prostaglandin receptor agonists

Allergan
Oxazole derivatives useful as modulators of FAAH

Merck Sharp & Dohme
Substituted clavulanic acid

Nabriva Therapeutics
(aza)indole derivative and use thereof for medical purposes

Kissei Pharmaceutical
Apogossypolone derivatives as anticancer agents

Sanford-Burnham Medical Research Institute
Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use

Merck Sharp & Dohme
Mixed cocaine agonist/antagonist properties of (+)-methyl 4beta-(4-chlorophenyl)-1-methylpiperidine-3alpha-carboxylate, a piperidine-based analog of cocaine.

Georgetown University
Pharmacokinetic/pharmacodynamic relationship of benzodiazepines in the direct cortical stimulation model of anticonvulsant effect.

Leiden University
[1,2,3]triazolo[4,5-D]pyrimidine derivatives

Hoffmann-La Roche